cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

Overview of attention for article published in Breast Cancer Research and Treatment, December 2005

Altmetric Badge

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Method for breast cancer recurrence prediction under endocrine treatment

Grant US-11913078-B2

United States of America

Targeting the histone pathway to detect and overcome anthracyclin resistance

Grant US-11015226-B2

United States of America

Neuregulin antagonists and use thereof in treating cancer

Grant US-9556249-B2

United States of America

Method and kit for the detection of genes associated with PIK3CA mutation and involved in…

Grant US-8580496-B2

United States of America

Protein-binding doxorubicin peptide derivatives

Grant US-7803903-B2

United States of America